Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: https://www.zionexa.com/sitemap_index.xml User-agent:* |
Title | Home - |
Description | Next generation in-vivo Zionexa develops Molecular Imaging CDx for targeted therapies that will transform oncology by improving the patient’s pathway and quality of |
Keywords | N/A |
WebSite | zionexa.com |
Host IP | 208.97.138.119 |
Location | United States |
Site | Rank |
US$2,456,390
Last updated: 2022-10-27 10:07:46
zionexa.com has Semrush global rank of 4,308,887. zionexa.com has an estimated worth of US$ 2,456,390, based on its estimated Ads revenue. zionexa.com receives approximately 283,430 unique visitors each day. Its web server is located in United States, with IP address 208.97.138.119. According to SiteAdvisor, zionexa.com is safe to visit. |
Purchase/Sale Value | US$2,456,390 |
Daily Ads Revenue | US$2,268 |
Monthly Ads Revenue | US$68,024 |
Yearly Ads Revenue | US$816,277 |
Daily Unique Visitors | 18,896 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
zionexa.com. | A | 1800 | IP: 208.97.138.119 |
zionexa.com. | NS | 3600 | NS Record: ns60.domaincontrol.com. |
zionexa.com. | NS | 3600 | NS Record: ns59.domaincontrol.com. |
zionexa.com. | MX | 3600 | MX Record: 0 zionexa-com.mail.protection.outlook.com. |
zionexa.com. | TXT | 3600 | TXT Record: hes=0f6cef991227e3dd75a1be0d629e3257 |
zionexa.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
zionexa.com. | TXT | 3600 | TXT Record: google-site-verification=31yAoTuLG8RE4h8t7zr92zENJ-8DQuLx4l2FYqEmF8Y |
zionexa.com. | TXT | 3600 | TXT Record: MS=ms89782379 |
About Pipeline EstroTep/Cerianna Breast Cancer Metastatic Breast Cancer Biomarkers’ role for treatment decision Critical role of tumor heterogeneity EstroTep, innovative in-vivo biomarker Extensive clinical development of Fluoroestradiol Z-FLD Lymphoma Z-FLD Publications LBT 999 Parkinson’s disease LBT-999 Publications Molecular Imaging News Careers Contact About Pipeline EstroTep/Cerianna Breast Cancer Metastatic Breast Cancer Biomarkers’ role for treatment decision Critical role of tumor heterogeneity EstroTep, innovative in-vivo biomarker Extensive clinical development of Fluoroestradiol Z-FLD Lymphoma Z-FLD Publications LBT 999 Parkinson’s disease LBT-999 Publications Molecular Imaging News Careers Contact Zionexa USA and PETNET Solutions announce FDA approval of Cerianna™ (fluoroestradiol F18) JUST ANNOUNCED VIEW PRESS RELEASE Improving Patient Pathways and Quality of Life MOLECULAR IMAGING SOLUTIONS FOCUSED ON Launch In-vivo Biomarkers for Molecular Imaging NEXT GENERATION VIEW |
HTTP/1.1 301 Moved Permanently Date: Sat, 12 Mar 2022 08:23:29 GMT Server: Apache Location: http://www.zionexa.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 301 Moved Permanently Date: Sat, 12 Mar 2022 08:23:29 GMT Server: Apache Expires: Sat, 12 Mar 2022 09:23:31 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Upgrade: h2 Connection: Upgrade Location: https://www.zionexa.com/ Vary: User-Agent Content-Type: text/html; charset=UTF-8 HTTP/2 200 date: Sat, 12 Mar 2022 08:23:32 GMT server: Apache cache-control: max-age=600 expires: Sat, 12 Mar 2022 08:33:32 GMT vary: User-Agent content-type: text/html; charset=UTF-8 |
Domain Name: ZIONEXA.COM Registry Domain ID: 2243785305_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-03-23T08:41:24Z Creation Date: 2018-03-26T11:38:51Z Registry Expiry Date: 2022-03-26T11:38:51Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-12T08:26:17Z <<< |